Last reviewed · How we verify
Blood draw for the laboratory assessment
Blood draw for laboratory assessment involves the collection of blood samples for diagnostic testing.
Blood draw for laboratory assessment involves the collection of blood samples for diagnostic testing. Used for Laboratory assessment.
At a glance
| Generic name | Blood draw for the laboratory assessment |
|---|---|
| Sponsor | Sanofi |
| Modality | Small molecule |
| Phase | Phase 2 |
Mechanism of action
This process typically involves the insertion of a needle into a vein, followed by the collection of a blood sample in a test tube. The blood sample is then sent to a laboratory for analysis, where various tests can be performed to diagnose and monitor various medical conditions.
Approved indications
- Laboratory assessment
Common side effects
- Bruising or hematoma at the needle site
Key clinical trials
- Screening and Multiple Intervention on Lung Epidemics (PHASE2)
- Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer (PHASE2)
- Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma (PHASE3)
- Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors (PHASE2)
- Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial (PHASE3)
- NCI COVID-19 in Cancer Patients, NCCAPS Study
- Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Immunotherapy (Nivolumab With or Without Ipilimumab) in Patients With Advanced Solid Cancers That Have Changes in the Following Genes: PIK3CA and PTEN (PHASE1, PHASE2)
- Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Blood draw for the laboratory assessment CI brief — competitive landscape report
- Blood draw for the laboratory assessment updates RSS · CI watch RSS
- Sanofi portfolio CI